Hepatitis B Virus Seroconversion in HIV-HBV Coinfected Patients Treated With Highly Active Antiretroviral Therapy
- 1 April 2000
- journal article
- Published by Ovid Technologies (Wolters Kluwer Health) in JAIDS Journal of Acquired Immune Deficiency Syndromes
- Vol. 23 (4), 356-357
- https://doi.org/10.1097/00042560-200004010-00013
Abstract
No abstract availableThis publication has 8 references indexed in Scilit:
- Long-term incidence of hepatitis B virus resistance to lamivudine in human immunodeficiency virus-infected patientsHepatology, 1999
- Resolution of Chronic Hepatitis B after Ritonavir Treatment in an HIV-Infected PatientNew England Journal of Medicine, 1999
- Lamivudine for chronic hepatitis B and HIV co-infectionAIDS, 1999
- Chronic Active Hepatitis B Exacerbations in Human Immunodeficiency Virus‐Infected Patients Following Development of Resistance to or Withdrawal of LamivudineClinical Infectious Diseases, 1999
- Hepatitis C virus-associated hepatitis following treatment of HIV-infected patients with HIV protease inhibitorsAIDS, 1998
- Restoration of immunity to chronic hepatitis B infection in HIV-infected patient on protease inhibitorThe Lancet, 1997
- Spontaneous hepatitis B surface antigen clearance in a long-term follow-up study of patients with chronic type B hepatitis. Lack of correlation with hepatitis C and D virus superinfectionThe Esophagus, 1996
- Effect of Alpha-Interferon Treatment in Patients with Hepatitis B e Antigen-Positive Chronic Hepatitis BAnnals of Internal Medicine, 1993